Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04535869 |
|---|---|
| Brief Title: | Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19) (CCOVID-19) |
| First Submitted : | August 28, 2020 |
| First Submitted that Met QC Criteria : | August 31, 2020 |
| First Posted : | September 2, 2020 |
| Last Update Submitted that Met QC Criteria : | February 22, 2021 |
| Last Update Posted : | February 24, 2021 |